These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1365 related articles for article (PubMed ID: 17932100)

  • 1. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of non-ergot dopamine agonists on health-related quality of life of patients with restless legs syndrome.
    Talati R; Phung OJ; Mather J; Coleman CI
    Ann Pharmacother; 2009 May; 43(5):813-21. PubMed ID: 19401472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
    Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
    Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep).
    Allen RP; Kosinski M; Hill-Zabala CE; Calloway MO
    Sleep Med; 2009 May; 10(5):531-9. PubMed ID: 18805054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
    Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
    Hornyak M; Hundemer HP; Quail D; Riemann D; Voderholzer U; Trenkwalder C
    Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
    Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
    Cuellar NG; Ratcliffe SJ
    Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dopamine agonists in restless legs syndrome.
    Hornyak M; Trenkwalder C; Kohnen R; Scholz H
    Sleep Med; 2012 Mar; 13(3):228-36. PubMed ID: 22281001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
    Stiasny K; Röbbecke J; Schüler P; Oertel WH
    Sleep; 2000 May; 23(3):349-54. PubMed ID: 10811379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.